 |
| 16 November, 2020 |
 |
| Latest News |
| Money Management Research | | The funds set to benefit from vaccine deal | | As markets react to the news of a successful COVID-19 vaccine trial from US pharma Pfizer and German biotech firm BioNTech, there are just three funds holding these stocks. |
|
|
|
| Money Management Research | | The firm returning 200% since IPO | | While initial public offering listings have fallen overall this year, one firm which went ahead with its Australian Securities Exchange float has returned 200% since its April listing. |
|
|
|
 |
| Money Management Research | | Four-fold increase in ETF inflows | | Assets in exchange-traded funds increased in October by four times as much as in September, taking one Australian equities ETF to more than $6 billion in assets. |
|
|
|
| Industry News | | What would encourage Aussies to invest? | | Reasons cited by Aussies for not investing included a preference to keep money in a bank account, belief it was too risky and lack of financial education. |
|
|
|
 |
| Money Management Research | | Does the 60/40 split have a future? | | The 60/40 split between equities and bonds has been a reliable strategy for mixed asset allocators in the past, but the new market environment has challenged the future of this strategy. |
|
|
|
| Money Management Research | | Indian equity funds struggle to make returns | | As the number of COVID-19 cases for the country is the second highest in the world, Indian equity funds are looking to government stimulus and reforms to support the country’s economic recovery. |
|
|
|
| |
| |
